Korsten, Mark A.
Lyons, Brian L.
Radulovic, Miroslav
Cummings, Tradd M.
Sikka, Gautam
Singh, Kamaldeep
Hobson, Joshua C.
Sabiev, Anton
Spungen, Ann M. http://orcid.org/0000-0003-2242-2119
Bauman, William A.
Article History
Received: 17 May 2017
Revised: 18 September 2017
Accepted: 22 September 2017
First Online: 8 November 2017
Compliance with ethical standards
:
: M.A.K. and W.A.B. are co-inventors of this bowel intervention and have processed a patent (patent number: 7.635,709) and a provisional patent (62/2984,874) for the administration of neostigmine and glycopyrrolate via iontophoresis through the Office of Technology Transfer Program, Department of Veterans Affairs. M.A.K. reports grants from Department of Veteran Affairs Rehabilitation Research and Development Service, during the conduct of the study; In addition, M.A.K. has a patent 7.635,709 licensed to Technology Transfer Program of the Department of Veterans Affairs. W.A.B. reports grants from Department of Veteran Affairs Rehabilitation Research and Development Service, during the conduct of the study; In addition, W.A.B. has a patent 7.635,709 licensed to Technology Transfer Program of the Department of Veterans Affairs.